Inactive Instrument
Eurofins-Cerep Share Price Euronext Paris
Stocks
FR0012413771
Biotechnology & Medical Research
| Market Cap | 82.22M 94.29M 76.74M 70.53M 132M 8.99B 136M 909M 355M 4.47B 354M 346M 15.41B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 61.18M 70.17M 57.11M 52.49M 98.49M 6.69B 101M 677M 264M 3.33B 263M 258M 11.47B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.01% |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 10/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 10/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 22/05/2024 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.01% | +4,900.50% | - | - | 93.68M | ||
| +2.61% | +1.91% | +1.70% | +13.91% | 47.88B | ||
| -1.60% | -1.29% | +385.56% | +603.70% | 39.09B | ||
| -0.98% | +2.68% | +11.10% | +45.34% | 36.75B | ||
| +1.90% | +22.79% | +25.18% | +9.47% | 40.55B | ||
| +1.47% | +4.90% | +6.48% | +43.52% | 27.96B | ||
| -0.94% | -1.23% | - | - | 16.77B | ||
| +2.44% | +10.02% | +29.11% | +129.56% | 15.94B | ||
| +0.18% | -1.46% | +4.92% | +10.14% | 13.55B | ||
| -1.14% | +6.94% | -6.05% | -29.33% | 13.81B | ||
| Average | +0.39% | +4.66% | +57.25% | +103.29% | 28.03B | |
| Weighted average by Cap. | +0.61% | +5.06% | +73.07% | +124.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 46.44M 37.79M 34.73M 65.18M 4.42B 66.74M 448M 175M 2.2B 174M 170M 7.59B | 41.1M 47.14M 38.36M 35.26M 66.16M 4.49B 67.74M 455M 178M 2.24B 177M 173M 7.7B |
| Net income | 7.15M 8.21M 6.68M 6.14M 11.52M 782M 11.79M 79.13M 30.92M 389M 30.78M 30.11M 1.34B | 4.78M 5.49M 4.46M 4.1M 7.7M 523M 7.88M 52.89M 20.67M 260M 20.57M 20.13M 896M |
| Net Debt | -17.25M -19.79M -16.1M -14.8M -27.77M -1.89B -28.44M -191M -74.57M -939M -74.22M -72.62M -3.23B | -21.03M -24.12M -19.63M -18.04M -33.86M -2.3B -34.67M -233M -90.92M -1.14B -90.49M -88.54M -3.94B |
Employees
-
















